Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Br J Haematol. 2009 Mar 29;145(5):637–641. doi: 10.1111/j.1365-2141.2009.07670.x

Figure 1a.

Figure 1a

Overall survival is depicted in relationship to the presence of cytogenetic abnormalities (CA) in either randomly sampled (RS) bone marrow or focal lesion (FL) sites recognized on magnetic resonance imaging (MRI) examination. The worst outcome was observed in the 75 patients exhibiting CA in both RS and FL sites (RS+/FL+), whereas the two cohorts with RS- with FL (RS−/FL+) or without FL (RS−/FL−) enjoyed superior survival; those with RS+/FL− had an intermediate prognosis.